Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma

Abstract Pancreatic adenocarcinoma (PAAD) is a highly aggressive and lethal malignancy, characterized by late diagnosis, rapid progression, and poor response to conventional therapies. Altered nucleotide metabolism has recently been recognized as a critical driver of tumorigenesis, impacting cellula...

Full description

Saved in:
Bibliographic Details
Main Authors: Chaojie Zhai, Jiarong Ye, Ziyang Zhou, Hongliang Luo, Xiaoyan Li, Jipeng Liu, Xinchi Zhou, Zuao Wang, Xu Zhang, Wen Zeng, Leifeng Chen, Fan Zhou
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-10098-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333129047703552
author Chaojie Zhai
Jiarong Ye
Ziyang Zhou
Hongliang Luo
Xiaoyan Li
Jipeng Liu
Xinchi Zhou
Zuao Wang
Xu Zhang
Wen Zeng
Leifeng Chen
Fan Zhou
author_facet Chaojie Zhai
Jiarong Ye
Ziyang Zhou
Hongliang Luo
Xiaoyan Li
Jipeng Liu
Xinchi Zhou
Zuao Wang
Xu Zhang
Wen Zeng
Leifeng Chen
Fan Zhou
author_sort Chaojie Zhai
collection DOAJ
description Abstract Pancreatic adenocarcinoma (PAAD) is a highly aggressive and lethal malignancy, characterized by late diagnosis, rapid progression, and poor response to conventional therapies. Altered nucleotide metabolism has recently been recognized as a critical driver of tumorigenesis, impacting cellular proliferation, invasion, and immune evasion. However, the role of specific metabolic enzymes, such as NT5M (cytosolic 5′-nucleotidase, mitochondrial), in PAAD remains poorly understood. In this study, we employed an integrated approach combining comprehensive bioinformatics analysis with systematic in vitro functional assays to investigate the multifaceted roles of NT5M in PAAD. Our investigation focused on three key aspects: (1) establishing NT5M as a novel prognostic biomarker, with lower expression levels significantly correlating with poor clinical outcomes; (2) characterizing the association between NT5M expression and tumor microenvironment (TME) features; and (3) elucidating the mechanistic role of NT5M in immune regulation within PAAD. Importantly, we discovered that NT5M downregulation is associated with increased CXCL8 expression and subsequent PD-L1 upregulation, thereby reversing immune evasion in pancreatic cancer. These findings establish NT5M as both a valuable prognostic indicator for tumor progression and a promising therapeutic target for PAAD. The identification of these interconnected pathways provides a novel strategy for enhancing the efficacy of immune checkpoint blockade therapies, potentially overcoming the current limitations in pancreatic cancer immunotherapy.
format Article
id doaj-art-a0211dace3634f32b572d1c93a523536
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a0211dace3634f32b572d1c93a5235362025-08-20T03:45:59ZengNature PortfolioScientific Reports2045-23222025-07-0115111910.1038/s41598-025-10098-8Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinomaChaojie Zhai0Jiarong Ye1Ziyang Zhou2Hongliang Luo3Xiaoyan Li4Jipeng Liu5Xinchi Zhou6Zuao Wang7Xu Zhang8Wen Zeng9Leifeng Chen10Fan Zhou11Department of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityBiobank Center, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityDepartment of General Surgery, The Second Affiliated Hospital of Nanchang UniversityAbstract Pancreatic adenocarcinoma (PAAD) is a highly aggressive and lethal malignancy, characterized by late diagnosis, rapid progression, and poor response to conventional therapies. Altered nucleotide metabolism has recently been recognized as a critical driver of tumorigenesis, impacting cellular proliferation, invasion, and immune evasion. However, the role of specific metabolic enzymes, such as NT5M (cytosolic 5′-nucleotidase, mitochondrial), in PAAD remains poorly understood. In this study, we employed an integrated approach combining comprehensive bioinformatics analysis with systematic in vitro functional assays to investigate the multifaceted roles of NT5M in PAAD. Our investigation focused on three key aspects: (1) establishing NT5M as a novel prognostic biomarker, with lower expression levels significantly correlating with poor clinical outcomes; (2) characterizing the association between NT5M expression and tumor microenvironment (TME) features; and (3) elucidating the mechanistic role of NT5M in immune regulation within PAAD. Importantly, we discovered that NT5M downregulation is associated with increased CXCL8 expression and subsequent PD-L1 upregulation, thereby reversing immune evasion in pancreatic cancer. These findings establish NT5M as both a valuable prognostic indicator for tumor progression and a promising therapeutic target for PAAD. The identification of these interconnected pathways provides a novel strategy for enhancing the efficacy of immune checkpoint blockade therapies, potentially overcoming the current limitations in pancreatic cancer immunotherapy.https://doi.org/10.1038/s41598-025-10098-8Pancreatic adenocarcinoma (PAAD)NT5MCXCL8PD-L1Immune
spellingShingle Chaojie Zhai
Jiarong Ye
Ziyang Zhou
Hongliang Luo
Xiaoyan Li
Jipeng Liu
Xinchi Zhou
Zuao Wang
Xu Zhang
Wen Zeng
Leifeng Chen
Fan Zhou
Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
Scientific Reports
Pancreatic adenocarcinoma (PAAD)
NT5M
CXCL8
PD-L1
Immune
title Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
title_full Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
title_fullStr Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
title_full_unstemmed Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
title_short Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
title_sort bioinformatics analysis identifies nt5m modulates immune evasion through pd l1 via cxcl8 in pancreatic adenocarcinoma
topic Pancreatic adenocarcinoma (PAAD)
NT5M
CXCL8
PD-L1
Immune
url https://doi.org/10.1038/s41598-025-10098-8
work_keys_str_mv AT chaojiezhai bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT jiarongye bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT ziyangzhou bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT hongliangluo bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT xiaoyanli bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT jipengliu bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT xinchizhou bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT zuaowang bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT xuzhang bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT wenzeng bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT leifengchen bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma
AT fanzhou bioinformaticsanalysisidentifiesnt5mmodulatesimmuneevasionthroughpdl1viacxcl8inpancreaticadenocarcinoma